Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway

M. K. Siu, Y. C. Tsai, Y. S. Chang, J. J. Yin, F. Suau, W. Y. Chen, Y. N. Liu

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Transforming growth factor-β (TGFβ) is enriched in the bone matrix and serves as a key factor in promoting bone metastasis in cancer. In addition, TGFβ signaling activates mammalian target of rapamycin (mTOR) functions, which is important for the malignant progression. Here, we demonstrate that TGFβ regulates the level of microRNA-96 (miR-96) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer. The enhanced effects in cellular growth and invasiveness suggest that miR-96 functions as an oncomir/and metastamir. Supporting this idea, we identified a downstream target of the TGFβ-miR-96 signaling pathway to be AKT1S1 mRNA, whose translated protein is a negative regulator of mTOR kinase. Our findings provide a novel mechanism accounting for the TGFβ signaling and bone metastasis.

Original languageEnglish
Pages (from-to)4767-4776
Number of pages10
JournalOncogene
Volume34
Issue number36
DOIs
Publication statusPublished - Sep 3 2015

Fingerprint

Transforming Growth Factors
Sirolimus
MicroRNAs
Prostate
Neoplasm Metastasis
Bone and Bones
Bone Matrix
Prostatic Neoplasms
Phosphotransferases
Messenger RNA
Growth
Neoplasms
Proteins

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway. / Siu, M. K.; Tsai, Y. C.; Chang, Y. S.; Yin, J. J.; Suau, F.; Chen, W. Y.; Liu, Y. N.

In: Oncogene, Vol. 34, No. 36, 03.09.2015, p. 4767-4776.

Research output: Contribution to journalArticle

@article{79cb29b720dc4b72bfd2853afa6ed6c7,
title = "Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway",
abstract = "Transforming growth factor-β (TGFβ) is enriched in the bone matrix and serves as a key factor in promoting bone metastasis in cancer. In addition, TGFβ signaling activates mammalian target of rapamycin (mTOR) functions, which is important for the malignant progression. Here, we demonstrate that TGFβ regulates the level of microRNA-96 (miR-96) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer. The enhanced effects in cellular growth and invasiveness suggest that miR-96 functions as an oncomir/and metastamir. Supporting this idea, we identified a downstream target of the TGFβ-miR-96 signaling pathway to be AKT1S1 mRNA, whose translated protein is a negative regulator of mTOR kinase. Our findings provide a novel mechanism accounting for the TGFβ signaling and bone metastasis.",
author = "Siu, {M. K.} and Tsai, {Y. C.} and Chang, {Y. S.} and Yin, {J. J.} and F. Suau and Chen, {W. Y.} and Liu, {Y. N.}",
year = "2015",
month = "9",
day = "3",
doi = "10.1038/onc.2014.414",
language = "English",
volume = "34",
pages = "4767--4776",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "36",

}

TY - JOUR

T1 - Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway

AU - Siu, M. K.

AU - Tsai, Y. C.

AU - Chang, Y. S.

AU - Yin, J. J.

AU - Suau, F.

AU - Chen, W. Y.

AU - Liu, Y. N.

PY - 2015/9/3

Y1 - 2015/9/3

N2 - Transforming growth factor-β (TGFβ) is enriched in the bone matrix and serves as a key factor in promoting bone metastasis in cancer. In addition, TGFβ signaling activates mammalian target of rapamycin (mTOR) functions, which is important for the malignant progression. Here, we demonstrate that TGFβ regulates the level of microRNA-96 (miR-96) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer. The enhanced effects in cellular growth and invasiveness suggest that miR-96 functions as an oncomir/and metastamir. Supporting this idea, we identified a downstream target of the TGFβ-miR-96 signaling pathway to be AKT1S1 mRNA, whose translated protein is a negative regulator of mTOR kinase. Our findings provide a novel mechanism accounting for the TGFβ signaling and bone metastasis.

AB - Transforming growth factor-β (TGFβ) is enriched in the bone matrix and serves as a key factor in promoting bone metastasis in cancer. In addition, TGFβ signaling activates mammalian target of rapamycin (mTOR) functions, which is important for the malignant progression. Here, we demonstrate that TGFβ regulates the level of microRNA-96 (miR-96) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer. The enhanced effects in cellular growth and invasiveness suggest that miR-96 functions as an oncomir/and metastamir. Supporting this idea, we identified a downstream target of the TGFβ-miR-96 signaling pathway to be AKT1S1 mRNA, whose translated protein is a negative regulator of mTOR kinase. Our findings provide a novel mechanism accounting for the TGFβ signaling and bone metastasis.

UR - http://www.scopus.com/inward/record.url?scp=84940961003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940961003&partnerID=8YFLogxK

U2 - 10.1038/onc.2014.414

DO - 10.1038/onc.2014.414

M3 - Article

C2 - 25531317

AN - SCOPUS:84940961003

VL - 34

SP - 4767

EP - 4776

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 36

ER -